Enliven Therapeutics Inc (ELVN) USD0.001
1.26%- This stock can be held in a
Stocks and Shares ISASell:$18.17
Buy:$18.21
Change:
$0.15
(0.82%)
$0.15
(0.82%)Market closed | Prices delayed by at least 15 minutes
Sell:$18.17
Buy:$18.21
Change:$0.15
(0.82%)
$0.15
(0.82%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 21 April 2025 | Joseph P (Joe) LyssikatosPresident | Sell Regular sell transaction (market) | 4,670 | $16.03 | $74,847.96 | 998,018 |
| 21 April 2025 | Joseph P (Joe) LyssikatosPresident | Sell Regular sell transaction (market) | 330 | $16.72 | $5,517.86 | 997,688 |
| 17 April 2025 | Samuel (Sam) KintzChairman/CEO | Sell Regular sell transaction (market) | 5,000 | $16.42 | $82,096.00 | 985,392 |
| 7 April 2025 | Anish PatelCOO | Sell Regular sell transaction (market) | 3,756 | $17.81 | $66,889.48 | 319,554 |
| 7 April 2025 | Anish PatelCOO | Sell Regular sell transaction (market) | 2,763 | $18.29 | $50,526.98 | 316,791 |
| 7 April 2025 | Anish PatelCOO | Sell Regular sell transaction (market) | 148 | $19.27 | $2,852.27 | 316,643 |
| 27 March 2025 | Benjamin (Ben) HohlCFO | Sell Option/Award related | 3,250 | $21.33 | $69,320.88 | 23,000 |
| 24 March 2025 | Benjamin (Ben) HohlCFO | Sell Option/Award related | 1,000 | $22.50 | $22,504.50 | 23,000 |
| 19 March 2025 | Joseph P (Joe) LyssikatosPresident | Sell Regular sell transaction (market) | 12,500 | $20.61 | $257,575.00 | 1,002,688 |
| 17 March 2025 | Samuel (Sam) KintzChairman/CEO | Sell Regular sell transaction (market) | 12,500 | $20.83 | $260,320.00 | 990,392 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 16 May 2024 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 1,000,000 | $22.14 | $22,140,000.00 | 7,663,349 |
| 9 October 2024 | Joseph P (Joe) LyssikatosPresident | Sell Regular sell transaction (market) | 34,289 | $28.12 | $964,203.25 | 1,019,624 |
| 15 July 2024 | Anish PatelCOO | Sell Regular sell transaction (market) | 30,978 | $25.05 | $776,039.17 | 345,574 |
| 16 May 2024 | ORBIMED ADVISORS LLCPrivate Equity | Sell Regular sell transaction (market) | 33,300 | $22.14 | $737,262.00 | 254,814 |
| 7 January 2025 | Anish PatelCOO | Sell Option/Award related | 20,260 | $24.15 | $489,329.65 | 1,440 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.